pharma news today obesity drugs glp-1 october 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Agonists Weight Loss Drugs
Description
analysis of treatment plans, including compounded GLP-1s, customers taking a compounded GLP-1 reported losing an average of 20.9 pounds or 10.3% of initial body weight, within six months, while reporting a low rate of side effects
We aimed to e...
Read Dr
Ultrasound assessments could improve risk stratification for perioperative management
Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition
The real problem seems to be retention
